MARK2 and type 2 diabetes mellitus: In T2DM, the activity of Akt, an upstream serine/threonine kinase of GSK‐3β that plays pivotal roles in cell metabolism, is generally inhibited as a result of insulin resistance, which is the main cause of glucose metabolism dysfunction, lipid accumulation, and protein synthesis inhibition in patients.3, 35